logo
Share SHARE
FONT-SIZE Plus   Neg

Dechra Pharma To Buy Eurovet Animal Health For EUR 135 Mln - Quick Facts

Dechra Pharmaceuticals Plc (DPH.L) has agreed terms to conditionally acquire the entire issued share capital of Eurovet Animal Health B.V., the pharmaceutical business of A.U.V. Holding B.V., for 135 million euros or some 112.5 million pounds, on a debt-free, cash-free basis.

The purchase would be funded with the proceeds of a fully underwritten rights issue to raise some 60 million pounds and debt as per the terms of a new debt facility. The Rights Issue would be made on the basis of 3 New Ordinary Shares for every existing 10 Ordinary Shares at a price of 300 pence per New Ordinary Share, representing a discount of 29.6 percent to the theoretical ex-rights price of 426.15 pence per Ordinary Share, based on a Closing Price of 464 pence per Ordinary Share on April 4, 2012.

The AUV and Eurovet management teams, on agreeing the transaction with Dechra as the preferred bidder, expressed a desire to select the right strategic partner, with a shared vision for product innovation, customer focus and growth, to help take Eurovet to its next stage of development.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
A California man has filed a lawsuit against McDonald's alleging that the fast food giant is defrauding customers by cramming its mozzarella sticks with filler instead of real cheese. Chris Howe is seeking at least $5 million in damages on behalf of consumers in 42 states and the District of Columbia. The... Jeep, the 4x4 vehicles, which has developed a strong bond with its masters, is aggressively on an expansion mode in its 75th anniversary year. Its fans have always been in love with the famous tag "Go Anywhere, Do Anything." Meat products maker Tyson Foods Inc. (TSN) reported a profit for the first-quarter that increased 49% from last year. It raised its profit outlook for fiscal year 2016 ,but it cut its annual sales guidance.
comments powered by Disqus
Follow RTT